How vaccine companies are responding to Omicron Scientists are scrambling to test and potentially update their vaccine candidates against the latest COVID variant of concern.
‘Alert but not alarmed’: What GPs need to know about Omicron Cases involving the newly named variant of concern have now been found in many countries, including Australia. What are the implications for general practice?
New COVID variant emerges in southern Africa B.1.1.529 has double the mutations of Delta and fuelled a rapid rise in cases in South Africa. What could it mean for vaccine-induced immunity?
Australian research provides COVID-19 vaccine hope The breakthrough comes after recent studies have suggested long-term immunity from natural infection may not be possible.
Free access to meningococcal B vaccination for high risk patients Aboriginal and Torres Strait Islander infants and people at risk of invasive meningococcal disease will be eligible under the NIP.
Testing for vitamin D rises again – at a cost of more than $100 m And the increase cannot be explained by clinical factors or changes in demographics.
Do vitamin D levels affect risk of infection and severity of COVID-19? Emerging research suggests yes, but others believe there is insufficient evidence to change current practice.
South Australia broadens meningococcal B vaccination scheme Australia’s only meningococcal B immunisation program has been expanded, giving South Australians aged 15–21 access to the free vaccines.
SA meningococcal B vaccination program to combat prevalence in the state The South Australian Government has committed $31 million to protect babies and young children from the potentially deadly disease – which is more prevalent in SA than any other state.